BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32647499)

  • 1. Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis.
    Xie Q; Wang L; Zheng S
    Dose Response; 2020; 18(2):1559325820931290. PubMed ID: 32647499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the C-reactive protein to albumin ratio in esophageal cancer: A systematic review and meta-analysis.
    Wang Y; Hu X; Huang Y; Xu WY; Wu YM; Li PF; Che GW
    Kaohsiung J Med Sci; 2020 Jan; 36(1):54-61. PubMed ID: 31512813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of C-reactive protein to albumin ratio in colorectal cancer patients: a meta-analysis.
    Fan Y; Xiang S; Dai Z; Zou C; Wang X; Gao Z
    Int J Colorectal Dis; 2019 Jun; 34(6):1105-1111. PubMed ID: 31016379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and clinicopathological significance of C-reactive protein/albumin ratio (CAR) in patients with gastric cancer: A meta-analysis.
    Yu J; Liu H; Zeng X; Zhao Y; Jiang D; Lu H; Qian J
    PLoS One; 2021; 16(4):e0250295. PubMed ID: 33901218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis.
    Xu HJ; Ma Y; Deng F; Ju WB; Sun XY; Wang H
    Onco Targets Ther; 2017; 10():3059-3070. PubMed ID: 28790840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Pancreatic Cancer: A Meta-Analysis.
    Fu W; Wang K; Yan S; Wang X; Tang B; Chang J; Wang R; Wu T
    Dose Response; 2020; 18(3):1559325820942065. PubMed ID: 32821253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Pretreatment Albumin-to-Globulin Ratio Predicts Poor Prognosis in Gastric Cancer: Insight From a Meta-Analysis.
    Wei C; Yu Z; Wang G; Zhou Y; Tian L
    Front Oncol; 2020; 10():623046. PubMed ID: 33575220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Role of Pretreatment C-Reactive Protein to Albumin Ratio in Urological Cancers: A Systematic Review and Meta-Analysis.
    Wu M; Zhou Y; Chen Q; Yu Z; Gu H; Lin P; Li Y; Liu C
    Front Oncol; 2022; 12():879803. PubMed ID: 35480099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of the C-reactive protein to albumin ratio in cancer: An updated meta-analysis.
    Cui X; Jia Z; Chen D; Xu C; Yang P
    Medicine (Baltimore); 2020 Apr; 99(14):e19165. PubMed ID: 32243358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-Reactive Protein to Albumin Ratio in Colorectal Cancer: A Meta-Analysis of Prognostic Value.
    Zhou QP; Li XJ
    Dose Response; 2019; 17(4):1559325819889814. PubMed ID: 31798355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of Nutrition and Inflammation in Esophageal Cancer Patients with Surgery: A Meta-Analysis.
    Yang Q; Shen A; Chen X; Guo L; Peng H; Gao M
    Nutr Cancer; 2022; 74(9):3128-3139. PubMed ID: 35341393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of the C-reactive protein to albumin ratio in colorectal cancer: an updated systematic review and meta-analysis.
    Liao CK; Yu YL; Lin YC; Hsu YJ; Chern YJ; Chiang JM; You JF
    World J Surg Oncol; 2021 May; 19(1):139. PubMed ID: 33933070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of the pretreatment C-reactive protein/albumin ratio in gastric cancer: A systematic review and meta-analysis.
    Yang X; Song X; Zhang L; Wu C
    Medicine (Baltimore); 2020 Mar; 99(10):e19362. PubMed ID: 32150079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and Clinicopathological Significance of MiR-155 in Hematologic Malignancies: A Systematic Review and Meta-analysis.
    Tang L; Peng YZ; Li CG; Jiang HW; Mei H; Hu Y
    J Cancer; 2019; 10(3):654-664. PubMed ID: 30719163
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic value of pretreatment C-reactive protein/albumin ratio in nasopharyngeal carcinoma: A meta-analysis of published literature.
    Yang X; Liu H; He M; Liu M; Zhou G; Gong P; Ma J; Wang Q; Xiong W; Ren Z; Li X; Zhang X
    Medicine (Baltimore); 2018 Jul; 97(30):e11574. PubMed ID: 30045284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of C-reactive protein to albumin ratio in colorectal cancer: A meta analysis.
    Wang F; Li P; Li FS
    Medicine (Baltimore); 2019 Jul; 98(29):e16064. PubMed ID: 31335668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of pre-treatment C-reactive protein/albumin ratio in esophageal cancer: a meta-analysis.
    Liu Z; Shi H; Chen L
    BMC Cancer; 2019 Nov; 19(1):1161. PubMed ID: 31783812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of albumin-to-globulin ratio in patients with renal cell carcinoma: a meta-analysis.
    Mao H; Yang F
    Front Oncol; 2023; 13():1210451. PubMed ID: 37538115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis.
    Zhang Y; Sun Y; Zhang Q
    Cancer Cell Int; 2020; 20():224. PubMed ID: 32528232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of C-reactive protein to albumin ratio in patients with lung cancer.
    Deng TB; Zhang J; Zhou YZ; Li WM
    Medicine (Baltimore); 2018 Dec; 97(50):e13505. PubMed ID: 30558004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.